Centurion+ Patent Holders as of May 7, 2024

Andrea Mahr

Director Companion Diagnostics bei Immatics.

Patent №: 11975058 (May 7, 2024) – Peptides and T cells for use in immunotherapeutic treatment of various cancers. The present invention pertains to peptides, proteins, nucleic acids, and cells used in cancer immunotherapy. It specifically involves tumor-associated T-cell peptide epitopes, either alone or combined with other peptides, for use in vaccines to stimulate anti-tumor immune responses. Additionally, these peptides can be used to activate T cells ex vivo before patient transfer, or they can serve as targets for antibodies, soluble T-cell receptors, and other binding molecules.

Umesh Phuyal

Senior Staff Engineer at Qualcomm.

Wireless communications expert specialized in 3GPP mobile communication standards and technologies (5G/NR, LTE, UMTS/HSPA, GSM) with expertise in MAC, RLC, PDCP and RRC specification.

Patent №: 11979919 (May 7, 2024) – Flexible random access channel configurations. 

The base station configures UE-specific preamble parameters, and the UE generates a random access preamble accordingly. Both entities exchange location information to calculate pre-compensation timing based on their distance.

Le Liu

Director, Technical Standards at Qualcomm.

Le Liu received a Ph.D. degree from Tohoku University, Japan, in 2007. She joined Qualcomm, Santa Clara, CA, USA, in 2017, where she has been working on 4G/5G R&D and standardization aspects.

Currently, her key research areas cover LTE MTC/NB-IoT features, NR multicast/broadcast features and NR potential vertical applications. She contributes to different international standardization activities, such as IEEE 802.11 and 3GPP RAN1.